Clinical Trials Directory

Trials / Completed

CompletedNCT02354651

Response to Diaphragmatic Pacing in Subjects With Pompe Disease

Status
Completed
Phase
Study type
Observational
Enrollment
9 (actual)
Sponsor
University of Florida · Academic / Other
Sex
All
Age
2 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine the effect of diaphragm pacing on respiratory function in subjects with Pompe disease by evaluating the duration and pattern of spontaneous respiratory function versus paced ventilation respiratory function in patients with Pompe disease who have received the NeuDx Diaphragm pacer (DPS).

Detailed description

Subjects with Pompe disease who are scheduled to receive a NeuRx Diaphragm pacer (DPS) will be invited to participate in this study. The following tests will be performed during participation in the study: 1. Forced expiratory tests 2. Maximal Inspiratory Pressure (MIP) 3. Resting Breathing Pattern 4. Phrenic Nerve Function Evaluation with EMG 5. Severe Respiratory Insufficiency Questionnaire 6. Magnetic stimulation 7. Diaphragm conditioning consisting of: 1. The external stimulator settings 2. The duration of diaphragm stimulation 3. Off-ventilator spontaneous breathing (SB)

Conditions

Interventions

TypeNameDescription
OTHERDiaphragm conditioning via phrenic nerve stimulationDiaphragm pacing will be prescribed by the patient's clinical team.

Timeline

Start date
2013-05-01
Primary completion
2022-06-01
Completion
2023-01-01
First posted
2015-02-03
Last updated
2023-08-01
Results posted
2023-06-05

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02354651. Inclusion in this directory is not an endorsement.